Pharmacological research

How fast-acting antidepressants work at the molecular level and new ideas for developing them

Updated

Abstract

Ketamine may produce rapid antidepressant effects by influencing multiple synaptic targets.

  • Conventional antidepressants often require several weeks to show significant effects, and about two-thirds of patients may not respond effectively.
  • Ketamine's antidepressant action involves not only NMDA receptor antagonism but also affects other receptors and channels in the synapse.
  • The mechanisms of ketamine include effects on α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors, adenosine A1 receptors, and L-type calcium channels.
  • Psilocybin, a 5-HT2A receptor agonist, has shown potential for rapid antidepressant effects in both mouse models and clinical studies.
  • The review highlights emerging pharmacological targets for rapid-acting antidepressants, suggesting new directions for future research.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest The authors declare no conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free